StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.75−0.06 (-1.57%)

Close on Nov 18, 2026Market cap $226.76MP/E –Yield –

Vanda Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Vanda Pharmaceuticals's gross margin for the twelve months ending Sep 30, 2026 was 93.6%. For fiscal 2025 it was 94.0%, against 94.3% the year before. The highest annual figure on record is 99.6% in fiscal 2012.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202594.0%−0.3
FY2024Dec 31, 202494.3%+2.0
FY2023Dec 31, 202392.3%+1.9
FY2022Dec 31, 202290.5%−0.0
FY2021Dec 31, 202190.5%−0.1
FY2020Dec 31, 202090.6%+1.4
FY2019Dec 31, 201989.2%−0.2
FY2018Dec 31, 201889.4%+10.7
FY2015Dec 31, 201578.7%−18.2
FY2014Dec 31, 201496.8%−2.8
FY2012Dec 31, 201299.6%+7.7
FY2010Dec 31, 201091.9%+34.0
FY2009Dec 31, 200957.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202694.1%−0.7
Q2 FY2026Jun 30, 202693.0%−1.8
Q1 FY2026Mar 31, 202693.9%+0.9
Q4 FY2025Dec 31, 202593.3%−1.8
Q3 FY2025Sep 30, 202594.7%+0.1
Q2 FY2025Jun 30, 202594.8%+0.2
Q1 FY2025Mar 31, 202593.0%+0.2
Q4 FY2024Dec 31, 202495.1%+2.8
Q3 FY2024Sep 30, 202494.6%+2.5
Q2 FY2024Jun 30, 202494.6%+2.2
Q1 FY2024Mar 31, 202492.8%+0.4
Q4 FY2023Dec 31, 202392.4%+2.0
Q3 FY2023Sep 30, 202392.1%+1.8
Q2 FY2023Jun 30, 202392.4%+1.8
Q1 FY2023Mar 31, 202392.4%+1.8
Q4 FY2022Dec 31, 202290.3%−0.5
Q3 FY2022Sep 30, 202290.3%+0.0
Q2 FY2022Jun 30, 202290.6%+0.3
Q1 FY2022Mar 31, 202290.6%+0.2
Q4 FY2021Dec 31, 202190.8%+0.9
Q3 FY2021Sep 30, 202190.3%+0.7
Q2 FY2021Jun 30, 202190.3%+0.3
Q1 FY2021Mar 31, 202190.4%−0.0
Q4 FY2020Dec 31, 202090.0%+0.8
Q3 FY2020Sep 30, 202089.6%+1.6
Q2 FY2020Jun 30, 202090.0%+1.4
Q1 FY2020Mar 31, 202090.4%+1.9
Q4 FY2019Dec 31, 201989.2%+0.6
Q3 FY2019Sep 30, 201988.0%−0.9
Q2 FY2019Jun 30, 201988.6%+0.4
Q1 FY2019Mar 31, 201988.5%−0.2
Q4 FY2018Dec 31, 201888.6%+0.4
Q3 FY2018Sep 30, 201888.9%+0.9
Q2 FY2018Jun 30, 201888.1%−0.1
Q1 FY2018Mar 31, 201888.7%+0.6
Q4 FY2017Dec 31, 201788.2%+7.5
Q3 FY2017Sep 30, 201788.0%–
Q2 FY2017Jun 30, 201788.2%–
Q1 FY2017Mar 31, 201788.1%–
Q4 FY2016Dec 31, 201680.7%–

More Vanda Pharmaceuticals figures

See a number that looks wrong?